Sandoz flags dosing table errors in co-amoxiclav oral suspension
Sandoz Limited has alerted the UK Medicines and Healthcare products Regulatory Agency (MHRA) to errors in the dosing table of the official product information for its co-amoxiclav oral suspension, a liquid antibiotic for children and adults. The MHRA has filed this as a Class 4 defect notice, the lowest-severity category, under reference EL(26)A/46. The error concerns the 250/62.5 mg per 5 mL strength.
This summary was generated by AI; the official source prevails.
What does it mean?
The leaflet that comes with this liquid antibiotic has a wrong dosing chart, so following it could mean giving the wrong amount. Anyone using the 250/62.5 mg per 5 mL version should check with a pharmacist or doctor before relying on the chart.
Who is affected?
Parents and carers giving this antibiotic liquid to children, and patients using it, along with pharmacists and prescribers who follow the dosing table.